Daily Mail, Tuesday, March 3, 2020^ Page 71
JACK Welch, who was credited with
transforming General Electric into
the world’s most valuable company,
has died at the age of 84.
The legendary businessman per-
sonified the so-called ‘cult of the CEO’
during the late 1990s boom, and
became a corporate leadership guru
in retirement.
Welch’s results-driven management
approach and hands-on style helped
GE turn a financial corner and sent its
share price soaring.
But some of the success came at the
expense of thousands of employees
who lost their jobs in Welch’s relent-
less efforts to cut costs and rid the
company of unprofitable businesses.
US President Donald Trump, pictured
with Welch above, led tributes. ‘There
was no corporate leader like “neu-
tron” Jack,’ he tweeted, ‘We made
wonderful deals together.’
In 1999, Fortune magazine named
him its manager of the century but
Welch found himself defending his
retirement compensation, which
included millions of dollars in bene-
fits, including unlimited personal use
of GE’s planes.
‘NeutroN’ jack welch,
legeNdary u.S. boSS, dieS
t
he race to develop a vac
cine against the corona
virus is heating up. In
Cambridge, researchers at
the university’s Infectious
Diseases Centre say work is ‘already
well under way’.
After further tests, they hope to send
the vaccine soon for preclinical trials
at Public health england.
In the US, Novavax has begun testing a
vaccine on animal models while the biotech
giant Gilead says human trials for its anti
viral drug, Remdesivir, have begun.
here in the UK, Glaxosmithkline has
hooked up with China’s biopharma special
ists, Clover, to help develop its protein
based vaccine – Covid19 STrimer – with
the aim that, if tested successfully, its
Chinese partner can produce large quanti
ties of it.
Another 30 to 40 pharma labs, including
those at Sanofi and Johnson & Johnson,
are also working at breakneck speed on new
designs. Some appear overly optimistic.
Israeli scientists working at Migal, the Gali
lee Research Institute, claim they have a
vaccine that could pass safety tests within
three months.
These breakthroughs are great. however,
even the most optimistic of scientists say it
will be at least a year before a vigorously
tested vaccine can be used on a mass scale
- in time for the next flu season, maybe.
Until then, we will have to wait and see
whether the midFebruary outbreaks may
have been the peak.
Much will depend now on how govern
ments tackle the tricky issue of public
health policy.
If they take the doomsday scenario of
lockdowns and selfisolation, the global
shortterm impact will be catastrophic. If
just London goes into lockdown, the UK
could be hit by a £10bn loss.
The OeCD’s latest warning, that the epi
demic is the gravest threat to the global
economy since the financial crisis, has con
firmed what many already feared. What’s
more, if the virus is not contained, it pre
dicts world GDP growth could be nearly
halved to 1.5pc with financial markets col
lapsing by up to 20pc. Countries such as
Japan, Italy and Germany will be tipped
into recession.
This epidemic is particularly devastating
because the blow to confidence is hitting
both supply and demand, with supply
chains around the world gummed up.
You can see this from the Baltic Dry Index,
one of the best measures of global activity,
which looks at freight rates across the big
shipping routes.
Since September, it is down by 84pc. After
the 2008 crash, it fell 90pc.
Stock markets which suffered painful falls
last week, did respond positively to the
news that central banks promised to do
what it takes to protect financial and mon
etary stability. That means interest rate
cuts and other measures to ease liquidity.
Investors should stay calm, for now.
The braver ones could try picking out
shares in the winning pharma companies:
one of the few positive antidotes to this
terrible scourge.
Hot water
The Quaker founders of Barclays would be
quaking in their straitlaced boots if they
could see what’s going on at their bank.
Chief executive Jes Staley is under attack
again over his ties to convicted paedophile,
the late Jeffrey epstein.
Staley is being investigated by the Finan
cial Conduct Authority over the nature of
his links to epstein, a former JP Morgan
client. Now Staley is under pressure from
activist investor, Sherborne’s edward
Bramson, who wants him removed.
Bramson claims the board’s decision to
reelect Staley at May’s annual meeting is
‘illadvised’.
Bramson is right. Chairman Nigel higgins
needs to stop quaking too, and step up his
authority. This could be done by announc
ing Staley will retire at some future date,
and that succession planning is in place.
While the American has done a decent job,
he has a habit of landing in hot water.
Staley was fined more than £1.1m in a
peculiar attempt to unmask a whistle
blower, prompting Barclays to claw back
£500,000 of his bonus. The link to epstein is
one bizarre incident too many.
A sad choice
TODAY is DDay for Sirius investors. The
80,000 or so small investors in the Yorkshire
potash mine have to vote on whether to
take the money from Anglo American or
risk Sirius going bust.
Many local investors have lost life savings.
It’s a sad choice, but a bird in the hand is
worth two in the bush.
keep the faith in pharma
barclays urged
to fire Staley
over epstein
The biggest shareholder in
Barclays has urged the bank
to fire boss Jes Staley over
h i s l i n k s t o p a e d o p h i l e
Jeffrey epstein.
US activist ed Bramson, who
owns 5.8pc of Barclays through
his hedge fund Sherborne
Investors, warned that re
electing Staley as chief execu
tive at its annual meeting in
May would be ‘extremely
ill advised’.
he called on chairman Nigel
higgins ‘to draw a line under
this destabilising situation,
which has become a circus, as
soon as possible’, adding that
any attempt to allow the US
banker to slip gracefully into
retirement ‘would be a mis
take and would set a terrible
precedent for Barclays and for
United Kingdom public com
panies in general’.
Barclays last month revealed
that Staley, 63, was being
investigated by the Financial
C o n d u c t A u t h o r i t y o v e r
whether he had been open
with his employer about his
link to epstein.
The Barclays boss went to
visit epstein in Florida in 2008
while he was serving his 13
month sentence for child sex
offences, and later joined him
at his Caribbean retreat.
Staley first met epstein in
2000 when he became head of
JP Morgan’s private bank,
where epstein was a client.
The US bank continued to
work with epstein until 2013 –
even after he pleaded guilty to
soliciting prostitution from an
underage girl in 2008. Staley
has said he deeply regrets
the relationship.
epstein committed suicide
in jail last year as he awaited
further charges. But Bramson
has now raised questions over
what Staley knew about the
paedophile’s illegal activities.
Bramson pointed out that
‘prostitution and sex traffick
ing, by their very nature,
involve the transfer of money’.
he added: ‘Given epstein’s
history of involvement in child
prostitution, it would be rea
sonable to expect that JP Mor
gan would have placed his
accounts under close scrutiny.
We do not know if any reports
were made, but, if they were
not, it raises obvious questions
and, if they were, why were the
accounts not closed?’
Bramson questioned whether
Staley maintained epstein as
a client because of the profits
he brought, and the benefits
which this lent Staley in terms
of pay and promotion.
The whole affair throws Sta
ley’s professional conduct into
significant doubt, he added.
Bramson said: ‘The real issue
is Staley’s professional conduct,
not the dubious company he
may have elected to keep.’
Barclays should also launch
a review into advice it received
over Staley’s appointment,
Bramson said, from JP Mor
gan and recruitment company
Spencer Stuart.
The lender declined to com
ment, but has maintained it
fully supports Staley.
Bramson’s criticism is the
latest salvo in a battle between
the activist and the Barclays
board. Shares in Barclays slid
3.7pc, or 5.44p, to 143.3p.
by Lucy White
Maggie
Pagano
Steel deal days away
The Chinese takeover of
British Steel should com
plete next week, following
months of nervous waiting
for its workers.
Jingye’s £50m purchase
will take legal effect on
Monday, with 3,700 staff
asked to sign new contracts
before the changes. But
another 400 will lose their
jobs on the same day.
It comes ten months after
British Steel collapsed, with
the firm kept afloat only by
state support.
Jingye first emerged as a
potential buyer in Novem
ber after Turkish pension
fund Ataer walked away.
The Chinese firm has
p r o m i s e d i t w i l l p u m p
£1.2bn into the business to
turn it around.
Some 20,000 supply chain
jobs rely on British Steel.
LEKOIL has hit out at its
consultant after it was
scammed out of £351,000
after believing the Qatari
sovereign wealth fund
would lend it £144m.
The London-listed oil firm
said it hired an unnamed
‘third-party global risk
consultant’ to look into
Seawave Invest, which
introduced it to ‘individu-
als falsely purporting to
represent’ the QIA fund.
However, it claimed that
an ‘inadequate’ due dili-
gence report did not raise
obvious red flags.
‘The fraud should have
been capable of being
detected,’ it added.
Lekoil said it has now
taken steps to recover the
fee paid to Seawave.
NeW rules on funding com
p a n y p e n s i o n s c h e m e s
proposed by the Pensions
R e g u l a t o r r i s k h u r t i n g
e m p l o y e e s a n d s a v e r s ,
experts have warned.
The rules aim to enforce a
tighter legal framework on
how much companies must
pay in and shorten deficit
reduction time.
T h e s u g g e s t i o n s a r e
designed to make sure pen
sion schemes actually pay
out. But pension consul
tancy LCP believes the rules
could force many compa
nies to close their schemes.
J o n a t h a n C a m f i e l d , a
partner at LCP, said: ‘Some
employers are likely to see a
significant increase in the
amount they have to con
tribute, and the combined
bill for UK plc is likely to
run into billions.’
Lekoil anger over scam Pension shake-up fear